PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

DC · US

Trade association of innovative biopharmaceutical research companies.

farapharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$77,232,500

Connections

34

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$124.7M
MMMMedicare/Medicaid
$120.7M
CPTCopyright/Patent/Trademark
$118.8M
TRDTrade
$118.4M
BUDBudget/Appropriations
$117.1M
PHAPharmacy
$4.1M
TAXTaxation/Internal Revenue Code
$410K
DEFDefense
$360K
CSPConsumer Protection
$350K
FORForeign Relations
$60K

Lobbying Firms Retained

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA$115.6M
AKIN GUMP STRAUSS HAUER & FELD$2.0M
EAST END GROUP, LLC$1.1M
TODD STRATEGY GROUP$940K
W STRATEGIES, LLC$840K
MILLER STRATEGIES, LLC$840K
THE MCMANUS GROUP$800K
CROSSROADS STRATEGIES, LLC$790K
EMPIRE CONSULTING GROUP$700K
BGR GOVERNMENT AFFAIRS$700K
FARRAGUT PARTNERS LLP$700K
LESIC AND CAMPER COMMUNICATIONS$700K
THORN RUN PARTNERS$590K
MARSHALL & POPP, LLC$560K
BRAVO GROUP$500K
AEGIS LLC$480K
SL STRATEGIES, LLC$428K
RADIUS ADVOCACY, LLC$420K
DLA PIPER LLP (US)$360K
Public Strategies Washington$350K
YC CONSULTING, LLC$340K
LMH STRATEGIC SOLUTIONS$250K
BOSE PUBLIC AFFAIRS GROUP$20K
ALTRIUS GROUP, LLC$15K
FEDERAL HEALTH COUNSEL, LLC$0

Bills Referenced in Lobbying Filings

march-inPBMS. 832H.R. 8333insulinUkraine supplemental

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byAKIN GUMP STRAUSS HAUER & FELDHired AKIN GUMP STRAUSS HAUER & FELD to lobby on PBM Reform ActSource
Lobbied forInsulin Price Caps - State-Level LegislationLDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $50,000Source
Employed byEMPIRE CONSULTING GROUPHired EMPIRE CONSULTING GROUP to lobby on Insulin Price CapsSource
Employed byPublic Strategies WashingtonHired PUBLIC STRATEGIES WASHINGTON, INC. to lobby on PharmaceuticalsSource
Employed byDLA PIPER LLP (US)Hired DLA PIPER LLP (US) to lobby on PharmaceuticalsSource
Employed byCROSSROADS STRATEGIES, LLCHired CROSSROADS STRATEGIES, LLC to lobby on PharmaceuticalsSource
Employed byLMH STRATEGIC SOLUTIONSHired LMH STRATEGIC SOLUTIONS to lobby on PharmaceuticalsSource
Employed byAEGIS LLCHired AEGIS LLC to lobby on PharmaceuticalsSource
Employed byMARSHALL & POPP, LLCHired MARSHALL & POPP, LLC to lobby on PharmaceuticalsSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $40,000Source
Lobbied forMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source
Lobbied forBIOSECURE Act (H.R.8333/S.3558)LDA filing: lobbied on BIOSECURE Act, period 4th Quarter (Oct 1 - Dec 31), reported amount $7,560,000Source
Lobbied forUkraine Security Assistance SupplementalLDA filing: lobbied on Ukraine Security Supplemental, period 1st Quarter (Jan 1 - Mar 31), reported amount $7,990,000Source
Lobbied forSugar Reform Act (S.832, 118th Congress)LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $12,880,000Source
commented_onFederal Trade CommissionPublic comment on FTC-2023-0040: Premerger Notification; Reporting and Waiting Period RequirementsSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2025-0058: Transparency in Coverage CMS-9882-PSource
Lobbied forAction to Delay Effective Date Consistent With Congressionally Enacted MoratoriumLobbied on pbm — matched LDA filing topic to Federal Register rule.Source
Lobbied forRights to Federally Funded Inventions and Licensing of Government Owned InventionsLobbied on march-in — matched LDA filing topic to Federal Register rule.Source
Employed byTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byFARRAGUT PARTNERS LLPHired FARRAGUT PARTNERS LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byLESIC AND CAMPER COMMUNICATIONSHired LESIC AND CAMPER COMMUNICATIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byTHORN RUN PARTNERSHired THORN RUN PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byRADIUS ADVOCACY, LLCHired RADIUS ADVOCACY, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byBOSE PUBLIC AFFAIRS GROUPHired BOSE PUBLIC AFFAIRS GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byEAST END GROUP, LLCHired EAST END GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byFEDERAL HEALTH COUNSEL, LLCHired FEDERAL HEALTH COUNSEL, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byBGR GOVERNMENT AFFAIRSHired BGR GOVERNMENT AFFAIRS to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byBRAVO GROUPHired BRAVO GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byW STRATEGIES, LLCHired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byTHE MCMANUS GROUPHired THE MCMANUS GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed bySL STRATEGIES, LLCHired SL STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byALTRIUS GROUP, LLCHired ALTRIUS GROUP, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2023)Source
Employed byMILLER STRATEGIES, LLCHired MILLER STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byYC CONSULTING, LLCHired YC CONSULTING, LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2023)Source